Jacobson Pharma

Jacobson Pharma's reported carbon emissions

In 2025, Jacobson Pharma reported total carbon emissions of approximately 21,101,630 kg CO2e. This figure includes Scope 1 emissions of about 1,196,010 kg CO2e, Scope 2 emissions of approximately 19,645,690 kg CO2e (market-based), and Scope 3 emissions of about 259,930 kg CO2e. The company has set a near-term reduction target to decrease electricity usage intensity by at least 3% by FY2026, compared to a FY2020 baseline. This commitment reflects Jacobson Pharma's focus on improving energy efficiency across all facilities. In 2024, the total emissions were approximately 16,940,730 kg CO2e, with Scope 1 emissions at about 1,190,980 kg CO2e, Scope 2 emissions (market-based) at approximately 15,500,730 kg CO2e, and Scope 3 emissions at about 249,020 kg CO2e. In 2023, the company reported total emissions of approximately 63,219,040 kg CO2e, with Scope 1 emissions of about 39,452,960 kg CO2e, Scope 2 emissions at approximately 23,612,700 kg CO2e, and Scope 3 emissions of about 153,380 kg CO2e. Jacobson Pharma's emissions data is not cascaded from any parent company, indicating that the reported figures are independently sourced. The company continues to focus on sustainability and reducing its carbon footprint in alignment with industry standards.